Last 432.50 TWD
Change Today +2.50 / 0.58%
Volume 3.4M
3176 On Other Exchanges
Symbol
Exchange
Taiwan
As of 1:30 AM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

medigen biotechnology corp (3176) Snapshot

Open
447.00
Previous Close
430.00
Day High
450.00
Day Low
431.00
52 Week High
06/13/14 - 486.00
52 Week Low
08/22/13 - 168.00
Market Cap
60.0B
Average Volume 10 Days
1.7M
EPS TTM
-2.77
Shares Outstanding
138.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIGEN BIOTECHNOLOGY CORP (3176)

Related News

No related news articles were found.

medigen biotechnology corp (3176) Related Businessweek News

No Related Businessweek News Found

medigen biotechnology corp (3176) Details

Medigen Biotechnology Corp. focuses on the development of therapeutics for liver diseases and cancers in Taiwan. Its product portfolio includes PI-88 for reducing tumor recurrence after surgical resection of early hepatocellular carcinoma (HCC); and Telomelysin, an oncolytic virotherapy for head and neck cancers, and HCC treatment. It is also developing MDCK cell-based H1N1 vaccines, which completed Phase I clinical trial and preclinical animal testing. In addition, the company offers human leukocyte antigen test diagnostic kits, as well as focuses on manufacturing H5N1 clinical lots and developing EV71 vaccine. The company was founded in 1999 and is based in Taipei City, Taiwan.

Founded in 1999

medigen biotechnology corp (3176) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medigen biotechnology corp (3176) Key Developments

Medigen Presents at 2014 Asia Biotech Invest Conference, Jun-05-2014 10:20 AM

Medigen Presents at 2014 Asia Biotech Invest Conference, Jun-05-2014 10:20 AM. Venue: Sheraton Hong Kong Hotel & Towers, 20 Nathan Road, Kowloon, Hong Kong. Speakers: David Ma, Business Development Director.

Medigen Biotechnology Corp., Annual General Meeting, Jun 09, 2014

Medigen Biotechnology Corp., Annual General Meeting, Jun 09, 2014.

Medigen Biotechnology Corp. Presents at Bank of America Merrill Lynch - Taiwan, Technology & Beyond 2014, Mar-21-2014 04:30 PM

Medigen Biotechnology Corp. Presents at Bank of America Merrill Lynch - Taiwan, Technology & Beyond 2014, Mar-21-2014 04:30 PM. Venue: Shangri-La's Far Eastern Plaza Hotel, Taipei, Taiwan.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3176:TT 432.50 TWD +2.50

3176 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 3176.
View Industry Companies
 

Industry Analysis

3176

Industry Average

Valuation 3176 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 451.5x
Price/Book 18.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 432.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIGEN BIOTECHNOLOGY CORP, please visit www.medigen.com.tw. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.